Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
The Canadian Journal of Cardiology
|
April 14, 2010
New insights into caveolae, caveolins and endothelial function
Arpeeta Sharma, Carol Yu, Pascal N Bernatchez
International Journal of Vascular Medicine
|
October 21, 2011
Targeting endothelial dysfunction in vascular complications associated with diabetes
Arpeeta Sharma, Pascal N Bernatchez, Judy B de Haan
British Journal of Pharmacology
|
June 16, 2021
Animal models of diabetes-associated vascular diseases: an update on available models and experimental analysis
Judy S Y Choi, Judy B de Haan, Arpeeta Sharma
American Journal of Physiology. Cell Physiology
|
June 5, 2009
Myoferlin is critical for endocytosis in endothelial cells
Pascal N Bernatchez, Arpeeta Sharma, Pinar Kodaman, et al.
European Journal of Pharmacology
|
April 6, 2011
Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1
Arpeeta Sharma, Andy Trane, Carol Yu, et al.
The Journal of Clinical Investigation
|
August 2, 2011
A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice
Pascal Bernatchez, Arpeeta Sharma, Philip M Bauer, et al.
Vascular Pharmacology
|
May 19, 2011
Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo
Carol Yu, Arpeeta Sharma, Andy Trane, et al.
Biochemical and Biophysical Research Communications
|
November 1, 2011
Proteomic identification of dysferlin-interacting protein complexes in human vascular endothelium
Cleo Leung, Soraya Utokaparch, Arpeeta Sharma, et al.
Journal of Molecular and Cellular Cardiology
|
September 25, 2025
Targeting the NLRP3 Inflammasome-Gasdermin D Axis to Combat Cardiovascular Diseases
Judy S Choi, Mehnaz Pervin, James E Vince, et al.
European Journal of Pharmacology
|
February 8, 2011
β-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions
Vijay Sharma, Arpeeta Sharma, Varun Saran, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
The Canadian Journal of Cardiology
|
April 14, 2010
New insights into caveolae, caveolins and endothelial function
Arpeeta Sharma, Carol Yu, Pascal N Bernatchez
International Journal of Vascular Medicine
|
October 21, 2011
Targeting endothelial dysfunction in vascular complications associated with diabetes
Arpeeta Sharma, Pascal N Bernatchez, Judy B de Haan
British Journal of Pharmacology
|
June 16, 2021
Animal models of diabetes-associated vascular diseases: an update on available models and experimental analysis
Judy S Y Choi, Judy B de Haan, Arpeeta Sharma
American Journal of Physiology. Cell Physiology
|
June 5, 2009
Myoferlin is critical for endocytosis in endothelial cells
Pascal N Bernatchez, Arpeeta Sharma, Pinar Kodaman, et al.
European Journal of Pharmacology
|
April 6, 2011
Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1
Arpeeta Sharma, Andy Trane, Carol Yu, et al.
The Journal of Clinical Investigation
|
August 2, 2011
A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice
Pascal Bernatchez, Arpeeta Sharma, Philip M Bauer, et al.
Vascular Pharmacology
|
May 19, 2011
Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo
Carol Yu, Arpeeta Sharma, Andy Trane, et al.
Biochemical and Biophysical Research Communications
|
November 1, 2011
Proteomic identification of dysferlin-interacting protein complexes in human vascular endothelium
Cleo Leung, Soraya Utokaparch, Arpeeta Sharma, et al.
Journal of Molecular and Cellular Cardiology
|
September 25, 2025
Targeting the NLRP3 Inflammasome-Gasdermin D Axis to Combat Cardiovascular Diseases
Judy S Choi, Mehnaz Pervin, James E Vince, et al.
European Journal of Pharmacology
|
February 8, 2011
β-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions
Vijay Sharma, Arpeeta Sharma, Varun Saran, et al.
Page
of 4